VINPAI Aktie

 

Revenue of €3.6 million in the fourth quarter of 2025, bringing annual revenue to €10.2 million Order backlog of €4.1 million as of December 31, 2025 SAINT-DOLAY, France--(BUSINESS WIRE)--Regulatory News: Vinpai (ISIN: FR001400AXT1; ticker: ALVIN), a specialist in the design, manufacture and marketing of algae- and plant-based functional ingredients for the food and cosmetics industries, today announces its revenue for the financial year ended December 31, 2025. 2025 activity and revenue By segment Revenue – in €k (unaudited) 12/31/2025 12/31/2024 % change Food industry 9 327 7 599 +23% Cosmetics and nutraceuticals 882 1 558 -43% Total revenue 10 210 9 157 +11% By geography Revenue – in €k (unaudited) 12/31/2025 12/31/2024 % change France 2 214 2 641 -16% MEA 6 087 4 654 +31% Americas 1 009 1 015 -1% Europe (excluding France) 673 677 -1% APAC 228 170 +34% Total revenue 10 210 9 157 +11% In 2025, Vinpai's revenue amounted to €10,210k, up 11% compared with FY 2024. In Q4 2025, Vinpai record...

Filing of the draft of the tender offer expected by end of February 2026MUMBAI, India--(BUSINESS WIRE)--Regulatory News: This press release must not be published, distributed or transmitted, directly or indirectly, in the United States of America, Australia, Canada, South Africa or Japan. CAMLIN FINE SCIENCES LIMITED, a leading Indian group in shelf life solutions for flavour and health & wellness ingredients, listed on the National Stock Exchange of India Ltd and BSE Ltd. in Mumbai India (“CFSL”) reminds that it has completed the acquisition on November 27, 2025, by way of contribution in kind, of a majority stake in the share capital of Vinpai (ISIN: FR001400AXT1; mnémonique : ALVIN) representing 78,68% of share capital et 84.89% of voting rights of Vinpai, at a price of Euro 3.60 per Vinpai share (the “Block Acquisition”) from significant shareholders (the “Sellers”). Following the Block Acquisition, CFSL holds 78.68% of Vinpai's share capital and 75.06% of its voting rights, thereby exce...

SAINT-DOLAY, France--(BUSINESS WIRE)--Regulatory News: This press release must not be published, distributed or transmitted, directly or indirectly, in the United States of America, Australia, Canada, South Africa or Japan. Vinpai (ISIN: FR001400AXT1; ticker: ALVIN), a specialist in the design, manufacture and marketing of algae- and plant-based functional ingredients for the food and cosmetics industries (“Vinpai” or the “Company”), today reiterates, following on from its previous press releases, including that of 27 November 2025, that Camlin Fine Science Limited (" CFSL") acquired a majority stake in Vinpai's share capital on 27 November 2025, representing 78.68% of its share capital and 84.89% of its voting rights, at a price of €3.60 per Vinpai share, from certain shareholders of the Company (the "Block Acquisition")1 . CFSL informed the Company today of an adjustment to the timetable for filing the simplified cash-tender offer for all outstanding Vinpai shares, at the ...

  MUMBAI, India--(BUSINESS WIRE)--Regulatory News: This press release must not be published, distributed or transmitted, directly or indirectly, in the United States of America, Australia, Canada, South Africa or Japan. Further to the announcements made on March 13, June 24, September 29, and November 25, CAMLIN FINE SCIENCES LIMITED, a leading Indian group in shelf life solutions for flavour and health & wellness ingredients, listed on the National Stock Exchange of India Ltd and BSE Ltd. in Mumbai India (“CFSL”) has today completed the acquisition, by way of contribution in kind, of a majority stake in the share capital of Vinpai (ISIN: FR001400AXT1; mnémonique : ALVIN) representing 78,68% of share capital et 84.89% of voting rights of Vinpai, at a price of Euro 3.60 per Vinpai share (the “Block Acquisition”) from significant shareholders (the “Sellers”). Following the Block Acquisition, CFSL holds 78.68% of Vinpai's share capital and 75.06% of its voting rights, thereby exceeding the leg...

SAINT-DOLAY, France--(BUSINESS WIRE)--Regulatory News: This press release must not be published, distributed or transmitted, directly or indirectly, in the United States of America, Australia, Canada, South Africa or Japan. Vinpai (ISIN:FR001400AXT1; ticker: ALVIN), a specialist in the design, manufacture and marketing of algae- and plant-based functional ingredients for the food and cosmetics industries (“Vinpai” or the “Company”), today announces, following on from its previous press releases, including the one dated 24 February 2025, that Camlin Fine Science Limited (“CFSL”) has today completed the acquisition of a majority stake in the share capital of Vinpai, representing 78.68% of its share capital, at a price of EUR 3.60 per Vinpai share, from certain shareholders of the Company (the “Block Acquisition”)1. CFSL has indicated2 that on Monday, 1 December 2025, it would convert its convertible bonds issued on 20 October 2025 (the “Convertible Bonds”), thereby resulting in the issua...

MUMBAI, India--(BUSINESS WIRE)--Regulatory News: This press release must not be published, distributed or transmitted, directly or indirectly, in the United States of America, Australia, Canada, South Africa or Japan. CAMLIN FINE SCIENCES LIMITED, a leading Indian group in shelf life solutions for flavour and health & wellness ingredients, listed on the National Stock Exchange of India Ltd and BSE Ltd. in Mumbai India (“CFSL”) reminds that CFSL and the majority shareholders (the “Sellers”) of VINPAI (ISIN: FR001400AXT1; ticker: ALVIN) ( “Vinpai”) have on February 24, 2025 entered into a binding agreement for the acquisition by CFSL of a majority stake in the Company's share capital at a price of Euro 3.60 per Vinpai share (the “Block Acquisition”) as well as the issuance of convertible bonds to the benefit of CFSL representing financing necessary for the continuation of Vinpai's business (the “Convertible Bonds”). Upon completion of the Block Acquisition, the Convertible Bonds will b...

SAINT-DOLAY, France--(BUSINESS WIRE)--Regulatory News: This press release must not be published, distributed or transmitted, directly or indirectly, in the United States of America, Australia, Canada, South Africa or Japan. Vinpai (ISIN: FR001400AXT1; ticker: ALVIN), a specialist in the design, manufacture and marketing of algae- and plant-based functional ingredients for the food and cosmetics industries (“Vinpai” or the “Company”), today announces that Camlin Fine Science Limited (“CFSL”) received on November 18, 2025 all required Indian regulatory approvals for the issuance of new ordinary shares of CFSL (the “CFSL Consideration Shares”) at a price of INR 247.69 per share (EUR 2.39). The CFSL Consideration Shares are to be issued as consideration for the acquisition of a majority stake in Vinpai's share capital at a price of EUR 3.60 per Vinpai share sold by certain shareholders of the Company (the “Block Acquisition”)1. In line with these approvals, on November 24, 2025, CFSL's b...

Revenue of €2.4 million in the 3rd quarter of 2025, bringing revenue for the first nine months of 2025 to €7.3 million, up 11% SAINT-DOLAY, France--(BUSINESS WIRE)--Regulatory News: Vinpai (ISIN: FR001400AXT1; ticker: ALVIN), a specialist in the design, manufacture and marketing of algae- and plant-based functional ingredients for the food and cosmetics industries, today announces its revenue for the third quarter and the first nine months of the 2025 financial year. Philippe Le Ray, Chief Executive Officer and Co-founder, states: “After a difficult first half, we observe during the third quarter a rebound in demand for our solutions, particularly for cheese-making applications. We are consolidating this renewed commercial momentum by actively working on our planned combination with CAMLIN, notably by promoting VINPAI's solutions through its distribution network." Third Quarter 2025 Activity Revenue - in €k 2024 2025 % change 3rd quarter 1,793 2,365 +32% Total over 9 months 6,517 7,262 +11% ...

Camlin subscribed to new bonds convertible into Vinpai Shares for €3.3 million This subscription was completed exclusively through the set-off of receivables against the nominal amount of the convertible bonds issued on February 24, 2025 SAINT-DOLAY, France--(BUSINESS WIRE)--Regulatory News: This press release must not be published, distributed or transmitted, directly or indirectly, in the United States of America, Australia, Canada, South Africa or Japan. Vinpai (ISIN:FR001400AXT1; ticker: ALVIN), a specialist in the design, manufacture and marketing of algae- and plant-based functional ingredients for the food and cosmetics industries (“Vinpai” or the “Company”), today announces that Camlin Fine Sciences Limited (“Camlin”), has subscribed to 3,300 convertible bonds issued by the Company today (the “OC10-2025”) exclusively by way of set-off against the nominal amount of the bonds convertible into Vinpai shares issued to the benefit of Camlin on February 24, 20251 (the “OC02-2025”),...

SAINT-DOLAY, France--(BUSINESS WIRE)--Regulatory News: Vinpai (ISIN: FR001400AXT1; ticker: ALVIN), a specialist in the design, manufacture and marketing of algae- and plant-based functional ingredients for the food and cosmetics industries (“Vinpai” or the “Company”), today announces its results for the first half of 2025, ended June 30, 2025, approved by the Board of Directors on this date. Philippe Le Ray, Chief Executive Officer and Co-founder, states: "In a market where consumers are increasingly focused on lower prices, Vinpai is working to preserve its margins and maintain its financial balances, while advancing its strategic partnership with its Indian partner Camlin. This will provide Vinpai with a platform to market its offerings globally and accelerate sales." 2025 First Half-Year Results In €k (unaudited) 30/06/2025 30/06/2024 % Change Revenue 4,895 4,724 +3.6% Gross margin* 2,051 2,165 -5.3% EBITDA (673) (957) n.a Operating profit (963) (1,203) n.a Profit before tax (1,086)...

SAINT-DOLAY, France--(BUSINESS WIRE)--Regulatory News: This press release must not be published, distributed or transmitted, directly or indirectly, in the United States of America, Australia, Canada, South Africa or Japan. Vinpai (ISIN: FR001400AXT1; ticker: ALVIN), a specialist in the design, manufacture and marketing of algae- and plant-based functional ingredients for the food and cosmetics industries (“Vinpai” or the “Company”), today announces a delay to the previously communicated1 timetable for the acquisition of a majority stake in Vinpai by Camlin Fine Science Limited (“CFSL”) (the “Block Acquisition”). The parties intend to have the Block Acquisition completed by November 30, 2025, and thus announce the definitive timetable for the Block Acquisition. As previously announced, on February 24, 2025, CFSL and certain significant shareholders of Vinpai (the “Sellers”) entered into an agreement for the Block Acquisition (the “Share Purchase Agreement”), and CFSL subscribed to ...

SAINT-DOLAY, France--(BUSINESS WIRE)--Regulatory News: Vinpai (ISIN: FR001400AXT1; ticker: ALVIN), a specialist in the design, manufacture and marketing of algae- and plant-based functional ingredients for the food and cosmetics industries, today announces its revenue for the first half of 2025. Philippe Le Ray, Chief Executive Officer and Co-founder, states: “The upturn in sales in the 2nd quarter demonstrates Vinpai's resistance, despite the wait-and-see attitude of some of our customers, who are delaying the launch of their new projects. Our backlog to be delivered for the 3rd quarter totaling over €4million, also means that we can remain confident about sales in the 2nd half of the year”. First Half 2025 Activity Revenue - en K€ 2025 2024 % change 2nd quarter 2,576 2,172 +19% Total 6 months 4,898 4,724 +4% Revenue for the first half of 2025 amounts to €4,898k, up 4% compared to the reported revenue (published revenue, first half 2024 financial results). Sales recorded in the second quarter ...

Backlog1 increases to €5.4 million SAINT-DOLAY, France--(BUSINESS WIRE)--Regulatory News: Vinpai (ISIN: FR001400AXT1; ticker: ALVIN), a specialist in the design, manufacture and marketing of algae- and plant-based functional ingredients for the food and cosmetics industries, today announces its revenue for the first quarter of 2025. Philippe Le Ray, Chief Executive Officer and Co-founder, states: “After a challenging environment in 2024, the beginning of 2025 is marked by strong demand, as reflected by our robust backlog, now approaching €6 million. This first quarter appears to confirm an upward trend, with a rebound in North America, sustained demand in North Africa, and positive momentum in Asia-Pacific. Our industrial facility is now fully optimized to support a monthly revenue of over €1 million. We continue to leverage our innovation portfolio by integrating technologies we consider to be strategic across each of our areas of activity." First Quarter 2025 Activity Revenue - in €k Q1 2...

2024 revenue growth by 16% to €9.2 million, below the Company targets Gross margin rate at 44%, compared with 48.6% in 2023 EBITDA 2024 came to €-1.8 million and net income to €-2.9 million Sales momentum recovered in Q4 with a total backlog1 of over €3.8 million as of December 31, 2024 Camlin Fine Science Limited has fully subscribed to the Convertible Bonds issued in its favor for an amount of €3.3 million Confirmation of medium-term financial targets: Revenue of €16 million and EBITDA rate to revenue of over 10% by 20262 SAINT-DOLAY, France--(BUSINESS WIRE)--Regulatory News: Vinpai (ISIN: FR001400AXT1; ticker: ALVIN), a specialist in the design, manufacture and marketing of algae- and plant-based functional ingredients for the food and cosmetics industries, today announces its 2024 annual results, for the year ended December 31, 2024, approved by the Board of Directors on April 2, 2025. Philippe Le Ray, Chief Executive Officer and Co-founder, states: "In a global economic context marke...